Page last updated: 2024-10-18

dihydroxyphenylalanine and Osteoporotic Fractures

dihydroxyphenylalanine has been researched along with Osteoporotic Fractures in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Osteoporotic Fractures: Breaks in bones resulting from low bone mass and microarchitectural deterioration characteristic of OSTEOPOROSIS.

Research Excerpts

ExcerptRelevanceReference
"Drugs are normally prescribed to treat osteoporosis, especially after surgical treatment of osteoporotic fractures."1.91Bio-orthogonal engineered peptide: A multi-functional strategy for the gene therapy of osteoporotic bone loss. ( Bai, J; Chu, PK; Gao, A; Ge, G; Geng, D; Liu, X; Wang, G; Wang, H; Wang, Q; Wang, W; Wu, Z; Yu, L, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wang, W1
Wang, Q1
Yu, L1
Ge, G1
Liu, X1
Gao, A1
Wang, G1
Wu, Z1
Bai, J1
Wang, H1
Chu, PK1
Geng, D1

Other Studies

1 other study available for dihydroxyphenylalanine and Osteoporotic Fractures

ArticleYear
Bio-orthogonal engineered peptide: A multi-functional strategy for the gene therapy of osteoporotic bone loss.
    Biomaterials, 2023, Volume: 302

    Topics: Aged; Dihydroxyphenylalanine; Humans; Osteoporosis; Osteoporotic Fractures; Peptides; Reactive Oxyge

2023